MedPath

University of North Carolina - Chapel Hill Endowment Fund

πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Carolina Heart Alliance Networking for Greater Equity

Not Applicable
Completed
Conditions
Cardiovascular Disease (CVD)
Interventions
Behavioral: CHANGE Study
First Posted Date
2018-07-11
Last Posted Date
2019-10-08
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
386
Registration Number
NCT03582696
Locations
πŸ‡ΊπŸ‡Έ

OIC Family Medical Center, Rocky Mount, North Carolina, United States

πŸ‡ΊπŸ‡Έ

Roanoke Chowan Community Health Center, Ahoskie, North Carolina, United States

πŸ‡ΊπŸ‡Έ

Edgecombe Health Department, Tarboro, North Carolina, United States

and more 1 locations

Study of an International Commercial Program on Weight Loss and Health Outcomes

Not Applicable
Completed
Conditions
Obesity
Weight Loss
Weight Change, Body
Diet Modification
Interventions
Behavioral: DIY Personal Plan
Behavioral: Weight Watchers Freestyle (Flex)
First Posted Date
2018-06-28
Last Posted Date
2020-03-13
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
373
Registration Number
NCT03571893
Locations
πŸ‡ΊπŸ‡Έ

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

πŸ‡¨πŸ‡¦

University of British Columbia-Vancouver, Vancouver, British Columbia, Canada

πŸ‡¨πŸ‡¦

University of British Columbia-Okanagan, Kelowna, British Columbia, Canada

and more 1 locations

Arresting Vertical Transmission of Hepatitis B Virus

Phase 4
Completed
Conditions
Hepatitis B
Vertical Transmission of Infectious Disease
Interventions
Drug: Tenofovir Disoproxil Fumarate
Biological: Monovalent HBV vaccine
First Posted Date
2018-06-25
Last Posted Date
2021-02-24
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
179
Registration Number
NCT03567382
Locations
πŸ‡¨πŸ‡©

Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the

Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years

Phase 4
Completed
Conditions
Anesthesia, Local
Pain
First Posted Date
2018-06-19
Last Posted Date
2020-06-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
26
Registration Number
NCT03562481
Locations
πŸ‡ΊπŸ‡Έ

UNC School of Dentistry, Chapel Hill, North Carolina, United States

Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics

Not Applicable
Completed
Conditions
Moderate to Severe Asthma
Interventions
Device: 3% Hypertonic Saline
Device: 7% Hypertonic Saline
First Posted Date
2018-06-14
Last Posted Date
2024-07-15
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
22
Registration Number
NCT03556683
Locations
πŸ‡ΊπŸ‡Έ

Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

Not Applicable
Recruiting
Conditions
Intestinal Metaplasia
Barrett Esophagus
Esophageal Dysplasia
Interventions
Device: CryoBalloon Focal Ablation System
First Posted Date
2018-06-13
Last Posted Date
2024-07-17
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
70
Registration Number
NCT03554356
Locations
πŸ‡ΊπŸ‡Έ

Geisinger Clinic, Danville, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

Icahn School of Medicine at Mount Sinai, New York, New York, United States

πŸ‡ΊπŸ‡Έ

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

and more 9 locations

Project SOAR-Mental Health Malawi: Depression and HIV Integration

Not Applicable
Completed
Conditions
HIV/AIDS
Depression
Interventions
Other: Depression Treatment
First Posted Date
2018-06-13
Last Posted Date
2023-05-31
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
2082
Registration Number
NCT03555669
Locations
πŸ‡²πŸ‡Ό

Area 18 Clinic, Lilongwe, Malawi

πŸ‡²πŸ‡Ό

Area 25 Clinic, Lilongwe, Malawi

North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2

Not Applicable
Active, not recruiting
Conditions
Development Delay
Epilepsy; Seizure
Brain Malformation
Intellectual Disability
Skeletal Dysplasia
Congenital Abnormality
Macrocephaly
Genetic Disease
Microcephaly
Neuromuscular Diseases
Interventions
Behavioral: Pre-visit prep
Diagnostic Test: usual care + exome seq
First Posted Date
2018-06-07
Last Posted Date
2024-03-04
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
806
Registration Number
NCT03548779
Locations
πŸ‡ΊπŸ‡Έ

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

πŸ‡ΊπŸ‡Έ

East Carolina University, Greenville, North Carolina, United States

πŸ‡ΊπŸ‡Έ

Mission Health, Asheville, North Carolina, United States

Reducing Binge Eating to Prevent Weight Gain in Black Women

Not Applicable
Terminated
Conditions
Binge Eating
Weight Loss
Weight Gain Prevention
Interventions
Behavioral: Appetite Awareness Treatment + Lifestyle Modification
First Posted Date
2018-05-21
Last Posted Date
2021-12-17
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
20
Registration Number
NCT03531112
Locations
πŸ‡ΊπŸ‡Έ

Nutrition Research Institute, Kannapolis, North Carolina, United States

Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

Phase 1
Withdrawn
Conditions
Asthma
Interventions
Biological: Anakinra
Other: Anakinra Matching Placebo
Drug: Dermatophagoides Farinae
First Posted Date
2018-05-01
Last Posted Date
2021-05-14
Lead Sponsor
University of North Carolina, Chapel Hill
Registration Number
NCT03513458
Β© Copyright 2025. All Rights Reserved by MedPath